Relevium Launches New Line of HighEnd Omega Fish Oils Targeting Inflammation Heart and Vision
Relevium Launches New Line of High-End Omega Fish Oils Targeting Inflammation, Heart and Vision
Relevium Technologies Inc. (TSXV:RLV,OTCQB:RLLVF;FWB:6BX)(the “Company” or “Relevium”), is pleased to announce that its OTC business has launched a new line of omega fish oils based formulations targeting inflammation, heart and vision care.
More From BioPortfolio on "Relevium Launches New Line of High-End Omega Fish Oils Targeting Inflammation, Heart and Vision"